Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other financing activities (2025)

Traws Pharma's Other financing activities history spans 1 years, with the latest figure at $1.9 million for Q4 2025.

  • Quarterly results put Other financing activities at $1.9 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.4 million (changed N/A YoY), and the annual figure for FY2025 was $2.4 million, changed.
  • Other financing activities for Q4 2025 was $1.9 million at Traws Pharma, up from $178000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.9 million in Q4 2025 to a low of $123000.0 in Q1 2025.